Quality assurance by specification and achievement of goals in palliative cancer treatment

Cancer Treatment Reviews

Volumn 22, Issue SUPPL.1, 1996, Pages 41-49

  Porzsolt, Franz ^a   Wirth, Anja ^a   Mayer Steinacker, Regine ^a   Schulte, Michael ^a   Negri, Giovanni ^a   Suhr, Peter ^a   Link, Karl Heinz ^a   Gaus, Wilhelm ^a   Röttinger, Erwin M ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER SURVIVAL; CONFERENCE PAPER; FEMALE; HEALTH CARE POLICY; HUMAN; MAJOR CLINICAL STUDY; MALE; QUALITY CONTROL; RETROSPECTIVE STUDY; TREATMENT OUTCOME; TREATMENT PLANNING;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PALLIATIVE CARE; QUALITY ASSURANCE, HEALTH CARE; SURVIVAL RATE;

EID: 0029889187     PISSN: 03057372     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0305-7372(96)90062-6     Document Type: Article

References (22)

1. Porzsolt, F. (1994) Clinical economics: a new challenge for physicians. Klinikarzt 23: 441-448.
2. Donabedian, A. (1966) Evaluating the quality of medical care. Milbank Mem. Fund Quart. 44: 166-203.
3. Porzsolt, E. & Gaus, W. Nutzen Medizinischer Maßnahmen: Ein Beitrag zur Gesundheitsökonomie, Qualitätssicherung und Optimierung im Gesundheitswesen. Klinikarzt 22: 525-528.
4. Aaronson, N. K., Ahmedzai, S. & Bullinger, M. (1991) The EORTC core quality-of-life questionnaire: interim results of an international field study. In: Osoba, D. (ed.): Effect of Cancer on Quality of Life. Boca Raton, Boston, London, CRC Press Inc., pp. 185-203.
5. Enneking, W. F., Dunham, W., Gebhardt, M. C., Malawar, M. & Pritchard, D. J. (1993) A system for the functional evaluation of reconstructive procedures after surgical treatment of tumours of the muscoloskeletal system. Clin. Orthop. Related Res. 286: 242-246.
6. Schipper, H. & Levitt, M. (1995) Measuring quality of life: risks and benefits. Cancer Treat. Rep. 69: 1115-1125.
7. Ware, E. J. & Sherbourne, D. C. (1992) The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Medic. Care 30: 473-483.
8. Hopwood, P. & Osoba, D. (1992) Goals of palliative cancer therapies. ESPO News 7: 3-4.
9. Hossfield, D. (1992) Goals of palliative cancer therapy. UICC News III,3: 4.
10. Porzsolt, F., Heimpel, H. & Hossfeld, D. (1992) Ziele der palliativen Krebstherapie. Dtsch Ärzteblatt 37: 2974-2976.
11. Porzsolt, F. & Tannock, I. (1993) Goals of palliative cancer therapy. J. Clin. Oncol. 11: 378-381.
12. Porzsolt, F. & MacDonald, N. (1993) Palliation in cancer patients. J. Cancer Res. Clin. Oncol. 119: 504-505.
13. MacDonald, N. (1993) Oncology and palliative care: the case for co-ordination. Cancer Treat. Rev. 19 (Suppl. A): 29-42.
14. Rubens, R. D. (1993) Approaches to palliation and its evaluation. Cancer Treat. Rev. 19 (Suppl. A): 67-72.
15. Gelber, R. D., Goldhirsch, A. & Cole, B. F. (1993) Evaluation of effectiveness: Q-TWiST. Cancer Treat. Rev. 19 (Suppl. A): 73-84.
16. Kaplan, R. M. (1993) Quality of life assessment for cost-utility studies in cancer. Cancer Treat. Rev. 19 (Suppl. A): 85-96.
17. Goodwin, P. J. (1993) Economic factors in cancer palliation - methodologic considerations. Cancer Treat. Rev. 19 (Suppl. A): 59-66.
18. Silberman, G. (1993) Cancer palliation: economic and societal implications. Cancer Treat. Rev. 19 (Suppl. A): 97-102.
19. Heimpel, H., Loetzke, E. & Porzsolt, F. (1990) Nutzen und Probleme Interdisziplinärer Tumorkonferenzen. Langenbeck's Arch. Chir. Suppl. II: 55-8.
20. Kreuser, E. D., Anger, B. & Porzsolt, F. (1986) Ziele, Organisation und Akzeptanz des Interdisziplinären Onkologischen Konsils am Tumorzentrum der Universität Ulm. ATO 5: 56-62.
21. O'Shaugnessy, J. A., Wittes, R. E., Burke, G., Friedman, M. A., Johnson, J. R., Niederhuber, J. E., Rothenberg, M. L., Woodcock, J. Chabner, B. A. & Temple, R. (1991) Commentary concerning demonstration of safety and efficacy of investigational anti-cancer agents in clinical trials. J. Clin. Oncol 9: 2225-2232.
22. Porzsolt, F., Mayer-Steinacker, R. & Eggl, C. (1995) Effectiveness and utility of a second-line treatment in metastatic breast cancer. Onkologie 18: 48-53.